Acorda Therapeutics Inc
OTC:ACORQ

Watchlist Manager
Acorda Therapeutics Inc Logo
Acorda Therapeutics Inc
OTC:ACORQ
Watchlist
Price: 0.01 USD Market Closed
Market Cap: 20k USD

Wall Street
Price Targets

ACORQ Price Targets Summary
Acorda Therapeutics Inc

There are no price targets for ACORQ.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Acorda Therapeutics Inc Competitors:
Price Targets
FDMT
4D Molecular Therapeutics Inc
347% Upside
GNS
Genus PLC
4% Upside
GOSS
Gossamer Bio Inc
282% Upside
IDYA
IDEAYA Biosciences Inc
41% Upside
PTCT
PTC Therapeutics Inc
16% Upside
1530
3SBio Inc
45% Upside
6855
Ascentage Pharma Group International
95% Upside
EDIT
Editas Medicine Inc
148% Upside

Revenue
Forecast

Revenue Estimate
Acorda Therapeutics Inc

For the last 12 years the compound annual growth rate for Acorda Therapeutics Inc's revenue is -7%. The projected CAGR for the next 3 years is 9%.

-7%
Past Growth
9%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Acorda Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Acorda Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-71%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACORQ's stock price target?
Not Available

ACORQ doesn't have any price targets made by Wall Street professionals.

What is Acorda Therapeutics Inc's Revenue forecast?
Projected CAGR
9%

For the last 12 years the compound annual growth rate for Acorda Therapeutics Inc's revenue is -7%. The projected CAGR for the next 3 years is 9%.

Back to Top